Atreca Inc Cl A (BCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCEL | AZN | AMGN | GILD | BMY |
| Company | Atreca Inc Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0950 | 183.43 | 325.55 | 130.15 | 57.45 |
| High | 0.0950 | 184.74 | 325.77 | 131.05 | 58.50 |
| Low | 0.0900 | 182.67 | 321.21 | 129.22 | 57.08 |
| Latest | 0.0900 | 183.92 | 324.39 | 129.67 | 57.31 |
| Change | -0.0012 | +2.34 | -1.92 | +0.09 | +0.31 |
| % Change | -1.32% | +1.29% | -0.59% | +0.07% | +0.54% |
| Volume | 138,600 | 1,225,200 | 2,030,200 | 5,182,200 | 11,659,200 |
| 20-Day Average Volume | 104,865 | 2,078,105 | 2,677,830 | 6,295,875 | 10,350,465 |
| Previous Close | 0.0912 | 181.58 | 326.31 | 129.58 | 57.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0907 | 186.19 | 335.62 | 131.96 | 57.56 |
| 20-Day Raw Stochastic | 57.69% | 20.64% | 12.83% | 20.59% | 35.44% |
| 20-Day Relative Strength | 46.67 | 43.61 | 38.95 | 41.28 | 47.70 |
| Weighted Alpha | -88.45 | +24.25 | +13.13 | +15.95 | +22.46 |
| Today's Opinion | 56% Sell | 24% Sell | 40% Sell | 24% Sell | 8% Buy |
| Previous Opinion | 40% Sell | 24% Sell | 24% Sell | 16% Sell | 8% Buy |
| Last Month's Opinion | 72% Sell | 88% Buy | 56% Buy | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 06/07/24 | +1.13% since 05/11/26 | -1.58% since 05/11/26 | -2.88% since 05/11/26 | +2.95% since 05/11/26 |
| Low | 0.0864 on 06/10/24 | 180.55 on 05/15/26 | 321.21 on 05/18/26 | 129.10 on 05/15/26 | 55.45 on 05/12/26 |
| High | 0.0950 on 06/14/24 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 58.50 on 05/18/26 |
| 1-Month | |||||
| %Chg | -5.26% since 05/14/24 | -10.20% since 04/17/26 | -8.70% since 04/17/26 | -5.79% since 04/17/26 | -4.75% since 04/17/26 |
| Low | 0.0750 on 06/07/24 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 0.1010 on 05/21/24 | 203.37 on 04/20/26 | 356.90 on 04/20/26 | 138.54 on 04/20/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -54.77% since 03/14/24 | -11.86% since 02/18/26 | -14.57% since 02/18/26 | -15.10% since 02/18/26 | -4.05% since 02/18/26 |
| Low | 0.0520 on 03/19/24 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 0.2000 on 03/15/24 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 153.26 on 02/20/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -63.27% since 12/14/23 | +2.69% since 11/18/25 | -5.70% since 11/18/25 | +1.96% since 11/18/25 | +21.78% since 11/18/25 |
| Low | 0.0520 on 03/19/24 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.4448 on 01/12/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,566 | 281,613,888 | 176,104,624 | 160,882,640 | 116,398,048 |
| Shares Outstanding, K | 39,624 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -97,160,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -36,220,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.03 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/14/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 06/19/24 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.97 | 15.21 | 15.78 | 9.57 |